Quanzhong An, of Roslyn Heights, sentenced to prison for acting as an illegal agent of the Chinese government
Quanzhong An, 58, who a government attorney said has a net worth of $44 million and owns a large hotel in the heart of ...
The Canadian Press on MSN29m
UBC bans Chinese AI DeepSeek from its devices and networks, citing privacy, security
The University of British Columbia has banned Chinese AI tool DeepSeek's applications from being used or installed on ...
Canada says China executed four Canadians earlier this year
China executed four Canadians in recent months, Canada’s foreign affairs minister said Wednesday. Such executions of ...
Tesla's challenges run deeper than 'toxic' controversy around Elon Musk
The company is still valued at more than 100 times its earnings - but it faces problems that experts say go beyond questions ...
The Cornell Daily Sun24m
Free Features and Privacy Concerns: DeepSeek AI and it’s Growing Presence on Campus
Without the $200 per month subscription to ChatGPT pro, DeepSeek ’s new generative AI model performs similar OpenAI services ...
The Daily Star46m
Tk 721cr remittance: NBR suspects foul play
A businessman, who brought Tk 721 crore into the country claiming it as remittances, utilised the tax-exemption facility to repatriate funds that were earlier laundered abroad, tax officials believe.
Amnesty International Australia54m
Hong Kong: Article 23 law used to ‘normalise’ repression one year since enactment
Just one year after its passage, Hong Kong’s Article 23 law has further squeezed people’s freedoms and enabled authorities to ...
The Manila Times19m
HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025
Savolitinib is an oral, potent and highly selective MET tyrosine kinase inhibitor ("TKI”) being jointly developed and commercialized by AstraZeneca and HUTCHMED. In 2023, savolitinib and TAGRISSO ® ...